Objectives: In this first pathological session, the main microscopic features of sun-damaged skin lesions will be shown.

Results: Microscopic characteristics of elastoidosis, actinic keratoses, actinic lentigos and superficial basal cell carcinomas will be analyzed, in relation to clinical aspects and possible laser treatment.

Conclusion: What can be expected from pathological analyses for optimizing laser use on sun-damaged skin lesions will be discussed.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Objectives: The purpose of the presentation is to reduce the risk of dermato-oncological complications, as a result of using photo and laser technologies.

Introduction: How often do you think about whether it is a nevus when performing a procedure of laser hair removal and / or skin photorejuvenation?

Materials / method: The presentation is based on a 10-year analysis of the work of hundreds of specialists in the field of aesthetic medicine in Ukraine.

Results: Cancer vigilance of specialists is not at a high enough level.

Conclusion: Basic knowledge in the field of dermatologic oncology is a necessary skill for a specialist in aesthetic medicine.
To pay attention to this question is to save someone's life.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Objectives: To expose several ways to treat field of actinic damages with photodynamic therapy (PDT). From conventional PDT to low-dose rate PDT, adaptive modalities, advantages and drawbacks.

Introduction: PDT is an effective treatment for actinic damages. Nevertheless, it was known as a painful treatment. From few years, low-dose rate PDT permits a painless and effective treatment.

Materials / method: We expose results of real life experience in medical office with two low-dose rate PDT devices : one light emitting fabric and one low-dose white LED light.

Results: The two devices are particularly comfortable for the patient and for the practitioner: painless, easy to set and safe. The long duration of the session (2h30) can be a problem for certain patients but a comfortable installation permits a very good experience for most of all. Efficacy can be improved with laser assisted drug delivery (erbium yag fractionated treatment of the field before application of the photosensitizer) with the same good tolerance during the session and very few adverse effects the days after.

Conclusion: Low-dose rate PDT is a safe, painless and easy way to treat skin actinic damages.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
Yes
Please specify entities (individual, company, society): sciton - advisory board

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
Yes
Please specify entities (individual, company, society): IFC

Were you provided with any honoraria, payment or other compensation for your work on this study?
Yes
Please specify entities (individual, company, society): IFC

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work is presented thanks to the support of: IFC